# Clinical Evidence on Cannabinoids in PTSD and Substance Use > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-ptsd-clinical-evidence/ > **Published:** 2026-03-04T09:51:06-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:12:00-04:00 > **Clinical Summary:** Explore cannabinoids and PTSD clinical evidence showing trauma-focused treatments remain effective for patients with co-occurring substance use and cannabis use. --- #### Clinical Takeaway People with PTSD and co-occurring [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care based on a patient’s [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) status. ### #6 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data. **Citation:** Hill Melanie L et al. *[Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and trauma-focused treatment for co-occurring posttraumatic stress disorder and [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/): A meta-analysis of individual patient data.* Journal of [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/). 2024. PMID: 38266511. **Study type:** Meta-Analysis, Journal Article, Research Support, N.I.H., Extramural  |  **Topic area:** Anxiety & PTSD  |  **CED Score:** 12 Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2 Why This Matters This meta-analysis addresses a critical clinical gap by examining whether evidence-based PTSD treatments maintain efficacy in patients with concurrent cannabis use and comorbid substance use disorders, a population frequently excluded from or underrepresented in randomized trials. The findings provide empirical guidance for clinicians treating the substantial proportion of PTSD patients who use cannabis, informing whether standard trauma-focused protocols require modification or remain effective despite active cannabis use. Understanding treatment response across this common comorbidity pattern is essential for optimizing outcomes in real-world clinical settings where PTSD and polysubstance use frequently co-occur. **Quality Gate Alerts:** - Preclinical only **Abstract:** High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other substance use disorders (SUDs). Using a subset of four randomized [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use. Clinical Perspective This meta-analysis of individual patient data from trauma-focused [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) trials raises an important clinical question about whether cannabis use undermines evidence-based interventions in patients with co-occurring PTSD and substance use disorders, though the relatively small subset (drawn from four RCTs within a larger Project Harmony cohort) and potential selection bias warrant cautious interpretation of the findings. The heterogeneity of cannabis use patterns—including frequency, potency, route of administration, and whether cannabis is being used for self-medication versus recreation—represents a significant confounder that likely obscures meaningful clinical subtypes, and we should be careful not to treat “cannabis users” as a monolithic group in clinical decision-making. Additionally, the distinction between active cannabis use during treatment versus prior use history, as well as the role of concurrent psychosocial support and medication management, may substantially modify treatment outcomes in ways the current analysis may not fully capture. For practitioners, this work suggests that cannabis use should not automatically be viewed as a contraind  |   |  Further Reading CED Clinic Blog[Interactive effects of PTSD and substance use on suicidal ideation and behavior in military personnel: Increased risk from marijuana use](https://cedclinic.com/marijuana-use-ptsd-suicidal-risk-military-personnel/) Cannabis News[Recreational drugs triple the risk of stroke in young people, study finds | The Independent](https://cedclinic.com/recreational-drugs-stroke-risk-young-adults-study/) Cannabis Memes[College is hard lmao](https://cedclinic.com/college-is-hard-lmao/) Further Reading CED Clinic Blog[Interactive effects of PTSD and substance use on suicidal ideation and behavior in military personnel: Increased risk from marijuana use](https://cedclinic.com/marijuana-use-ptsd-suicidal-risk-military-personnel/) CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) CED Clinic Blog[Smart Cannabis Dosing](https://cedclinic.com/smart-cannabis-dosing/) [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/38266511/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138203/)[DOI ↗](https://doi.org/10.1016/j.janxdis.2024.102827) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoid Clinical Trials: PTSD and Substance Use Data](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/) Review clinical trial data on cannabinoids for PTSD and substance use disorders, highlighting recent research findings and implications. [Read More](https://cedclinic.com/cannabis-use-trauma-focused-treatment-ptsd-sud-outcomes/) [Endocannabinoid System Research: Cannabis for PTSD & SUD](https://cedclinic.com/endocannabinoid-system-ptsd-substance-use-research/) Explore research on the endocannabinoid system's role in PTSD and substance use disorder treatment with cannabis. [Explore Research](https://cedclinic.com/endocannabinoid-system-ptsd-substance-use-research/) [Cannabis in PTSD Treatment: Meta-Analysis of Trauma-Focused Care](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/) Meta-analysis insights on cannabis use during trauma-focused [PTSD treatment](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) and its clinical implications. [Learn More](https://cedclinic.com/cannabis-use-ptsd-treatment-outcomes-meta-analysis/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Clinical%20Evidence%20on%20Cannabinoids%20in%20PTSD%20and%20Substance%20Use&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-ptsd-clinical-evidence%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-ptsd-clinical-evidence%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Clinical%20Evidence%20on%20Cannabinoids%20in%20PTSD%20and%20Substance%20Use%20https%3A%2F%2Fcedclinic.com%2Fcannabinoids-ptsd-clinical-evidence%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).